Options Brief: Arena Pharmaceuticals

Shares of Arena Pharmaceuticals ARNA are higher on the session by 1.46%, trading at $1.39. Overall call volume is now running at 3.96x the daily average, with 78% of all calls traded being purchases on the offer. 2,846 contracts have traded on the session so far. Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.